Welcome to Coffee with the Coder®, our conversation with Paula Digby and her team to address issues, observations and questions for Health Information Management professionals, physicians, auditors, payors and students. Listen in for twenty minutes or so every other Monday and send in your favorite questions or comments for Coffee with the Coder® To receive text notifications send an email to help@AQ-IQ.com with your request. We will text you in the hour prior to the start of the next episode, which will be Monday, July 18th. The “Insider’s” topic for Episode 145 is the difference in reporting adverse drug events and poisonings, two different scenarios with differing approaches.  Paula Digby mentions the Adverse Drug Event Action Plan provided by the Office of Disease Prevention and Health Promotion. You can access this here: https://health.gov/our-work/national-health-initiatives/health-care-quality/adverse-drug-events/national-ade-action-plan Our first questioner is seeking guidance on reporting genetic testing for cancer patients, what to we need to know for this service line? The next item involves a patient with CVA with hemorrhagic conversion with mass effect, would that be I63.9 or  I61.9? After diving in to those concerns, Ms Digby assists with IGC selection for a patient in a motorcycle vs car trauma, is this best in 14.9? Congratulations Faith for winning today’s “mugging”! We appreciate your support! Coffee with the Coder(R) loves your questions.  To watch episode 145, click this sweet mugshot of Patricia. (Just so you know, the captions are not yet validated.) Connect for Episode 145 on July 5th, beginning at 10:10 am Eastern (7:10 am Pacific). “Insiders” begins at 10 am Eastern. You’ll find us on Free Conference Call HD,  Linked In, YouTube, and on Facebook. #coffeewiththecoder
Tagged with:

Comments are closed.